(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do INPI

YAVEMBO

Sabia que essa marca já está registrada no Brasil?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Registro de marca em vigor (Madri)Tipo: VerbalEscritório: Brasil
Ativar vigilância desta marcaFalar com especialista

Snapshot rápido

YAVEMBO

ST13

BR500000501674098

Classe

5, 10

Pedido

501674098

Registro

501674098
Ver no INPI

Andamento no INPI

  1. Depósito27/04/22
  2. Publicação10/01/23
  3. Exame
  4. Deferimento16/05/23
  5. Concessão26/12/23
  6. Vigente27/04/32

Registro concedido em 26/12/2023 e em vigor até 27/04/2032, quando precisa ser renovado.

Proteção válida até:27/04/2032

AlertaMarcas

Deixe seu contato e avisamos você

Acompanhamos as publicações do INPI e avisamos assim que houver movimentação neste processo.

Usamos seus dados apenas para este aviso.

Última movimentação publicada pelo INPI: 09/04/2024. Atualizamos a cada nova RPI, publicada semanalmente.

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação INPI

Registro de marca em vigor (Madri)

Tipo de processo

Pedido e registro

Eventos registrados

4

Atualização mais recente

09/04/2024

Tipo de marca

Verbal

Classes Nice

5, 10

Data de depósito

27/04/2022

Data de registro

26/12/2023

Data de expiração

27/04/2032

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Natureza

Madri Produto/Serviço

Escritório responsável

Brasil

Tipo de titular

NÃO RESIDENTE

Localização do titular

SE

Titulares e representantes

Titulares

Camurus AB

Representantes

Licks AdvogadosVer perfil do escritório

Classificação técnica

Classes Nice

Classe 5Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparationspharmaceutical preparations for injectionpharmaceutical preparation for subcutaneous injectionpharmaceutical preparations for the treatment of endocrine diseases and disorderspharmaceutical preparations for the treatment of tumourspharmaceutical preparations for the treatment of carcinoid tumourspharmaceutical preparations comprising peptides for hormonal treatment and tumour treatmentpharmaceutical preparations for the treatment of neuroendocrine tumourspharmaceutical preparations for the treatment of gastro-enteropancreatic neuroendocrine tumourspharmaceutical preparations for the treatment of gastrointestinal diseases and disorderspharmaceutical preparations for gastrointestinal bleeding disorderspharmaceutical preparations for the treatment of gastrointestinal bleeding disorderspharmaceutical preparations for the treatment of esophageal bleedingpharmaceutical preparations for metabolic disorderspharmaceutical preparations for the treatment of acromegalypharmaceutical preparations for the treatment of polycystic liver diseasepharmaceutical preparations for the treatment of respiratory diseases or syndromepharmaceutical preparations for the treatment of respiratory distress syndromepharmaceutical preparations for the treatment of acute respiratory distress syndromepharmaceutical preparations for the treatment of disorders of the autonomic nervous systempharmaceutical preparations intended to block growth hormone

Classe 10

Devices for administration of pharmaceuticals for the treatment of endocrine diseases and disordersdevices for administration of pharmaceuticals for the treatment of tumoursdevices for administration of pharmaceuticals for the treatment of carcinoid tumoursdevices for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatmentdevices for administration of pharmaceuticals for the treatment of neuroendocrine tumoursdevices for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumoursdevices for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disordersdevices for administration of pharmaceuticals for gastrointestinal bleeding disordersdevices for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disordersdevices for administration of pharmaceuticals for the treatment of esophageal bleedingdevices for administration of pharmaceuticals for metabolic disordersdevices for administration of pharmaceuticals for the treatment of acromegalydevices for administration of pharmaceuticals for the treatment of polycystic liver diseasedevices for administration of pharmaceuticals for the treatment of respiratory diseases or syndromedevices for administration of pharmaceuticals for the treatment of respiratory distress syndromedevices for administration of pharmaceuticals for the treatment of acute respiratory distress syndromedevices for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous systemdevices for administration of pharmaceuticals intended to block growth hormonesyringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorderssyringes for administration of pharmaceuticals for the treatment of tumourssyringes for administration of pharmaceuticals for the treatment of carcinoid tumourssyringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatmentsyringes for administration of pharmaceuticals for the treatment of neuroendocrine tumourssyringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumourssyringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorderssyringes for administration of pharmaceuticals for gastrointestinal bleeding disorderssyringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorderssyringes for administration of pharmaceuticals for the treatment of esophageal bleedingsyringes for administration of pharmaceuticals for metabolic disorderssyringes for administration of pharmaceuticals for the treatment of acromegalysyringes for administration of pharmaceuticals for the treatment of polycystic liver diseasesyringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndromesyringes for administration of pharmaceuticals for the treatment of respiratory distress syndromesyringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndromesyringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous systemsyringes for administration of pharmaceuticals intended to block growth hormonepens for administration of pharmaceuticals for the treatment of endocrine diseases and disorderspens for administration of pharmaceuticals for the treatment of tumourspens for administration of pharmaceuticals for the treatment of carcinoid tumourspens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatmentpens for administration of pharmaceuticals for the treatment of neuroendocrine tumourspens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumourspens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorderspens for administration of pharmaceuticals for gastrointestinal bleeding disorderspens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorderspens for administration of pharmaceuticals for the treatment of esophageal bleedingpens for administration of pharmaceuticals for metabolic disorderspens for administration of pharmaceuticals for the treatment of acromegalypens for administration of pharmaceuticals for the treatment of polycystic liver diseasepens for administration of pharmaceuticals for the treatment of respiratory diseases or syndromepens for administration of pharmaceuticals for the treatment of respiratory distress syndromepens for administration of pharmaceuticals for the treatment of acute respiratory distress syndromepens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous systempens for administration of pharmaceuticals intended to block growth hormonedevices for subcutaneous administration of pharmaceuticalsdevices for parenteral administration of pharmaceuticalsdevices for injection of pharmaceutical depotsdevices for subcutaneous injection of pharmaceutical depotdevices for parenteral injection of pharmaceutical depotdevices for injection of injection fluidsdevices for injection of injection depotsyringes for subcutaneous administration of pharmaceuticalssyringes for parenteral administration of pharmaceuticalssyringes for injection of pharmaceutical depotssyringes for subcutaneous injection of pharmaceutical depotsyringes for parenteral injection of pharmaceutical depotsyringes for injection of injection fluidssyringes for injection of injection depotsyringes for injectionssyringes for medical usespens for subcutaneous administration of pharmaceuticalspens for parenteral administration of pharmaceuticalspens for injection of pharmaceutical depotspens for subcutaneous injection of pharmaceutical depotpens for parenteral injection of pharmaceutical depotpens for injection of injection fluidspens for injection of injection depotpens for injectionspens for medical uses

Publicações

Histórico de despachos e eventos da marca no INPI.

4 publicações encontradas

IPAS270

Deferimento da petição

Protocolo: 850240109855 (08/03/2024) Petição (tipo): Nomeação, destituição ou substituição de procurador [em processo de registro] (385.1) Requerente: CAMURUS AB Procurador: Paulo de Tarso Castro Brandão Detalhes do despacho:Nomeado procurador Paulo de Tarso Castro Brandão com poderes para representar o titular do processo perante o INPI.

RPI 2779

09/04/2024

IPAS770

Concessão de registro em designação

RPI 2764

26/12/2023

IPAS768

Deferimento de designação

RPI 2732

16/05/2023

IPAS756

Publicação de pedido de registro para oposição (exame formal de designação concluído)

RPI 2714

10/01/2023

Camurus AB também protege tecnologia e design no INPI

8 pedidos de patente no mesmo titular.

Marcas relacionadas

Outras marcas de Camurus AB

OCLAIZOCZYESABOCASILBOCASILBOCASIL

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace YAVEMBO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o INPI por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.

Ativar vigilânciaFalar com especialista